Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Healthcare | 2.2% |
| 4 | Financials | 2.18% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZSQR
3726
Z Squared Inc
ZSQR
$223M
| $6.48M | ﹤0.01% |
32,550
-450
| -1% | -$88.9K |
|
3727
Global X Social Media ETF
SOCL
$93.2M
| $6.48M | ﹤0.01% |
106,135
+102,464
| +2,791% | +$6.73M |
|
3728
PUT
Spectrum Brands
SPB
$2.11B
| $6.48M | ﹤0.01% |
67,700
+56,400
| +499% | +$4.79M |
|
|
HCAQ
3729
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
| $6.47M | ﹤0.01% |
653,783
-30,343
| -4% | -$300K |
|
3730
PUT
Dynatrace
DT
$14.9B
| $6.46M | ﹤0.01% |
91,000
+24,500
| +37% | +$1.61M |
|
3731
CALL
Under Armour Class C
UA
$2.83B
| $6.46M | ﹤0.01% |
368,600
-25,300
| -6% | -$485K |
|
|
XIFR
3732
CALL
XPLR Infrastructure LP
XIFR
$1.09B
| $6.46M | ﹤0.01% |
85,700
-4,700
| -5% | -$367K |
|
3733
Bio-Rad Laboratories Class A
BIO
$9.16B
| $6.45M | ﹤0.01% |
8,652
-20,789
| -71% | -$15.6M |
|
|
SHCO
3734
DELISTED
Soho House & Co
SHCO
| $6.45M | ﹤0.01% |
+518,186
| New | +$6.48M |
|
3735
PUT
The Joint Corp
JYNT
$119M
| $6.44M | ﹤0.01% |
65,700
+26,700
| +68% | +$2.5M |
|
3736
CALL
Stride
LRN
$3.54B
| $6.44M | ﹤0.01% |
179,200
+23,200
| +15% | +$761K |
|
3737
Pebblebrook Hotel Trust
PEB
$2.18B
| $6.44M | ﹤0.01% |
287,265
+188,031
| +189% | +$4.16M |
|
3738
CALL
Equifax
EFX
$20.7B
| $6.44M | ﹤0.01% |
25,400
-15,800
| -38% | -$4.11M |
|
|
UNVR
3739
DELISTED
Univar Solutions Inc.
UNVR
| $6.43M | ﹤0.01% |
270,126
-45,946
| -15% | -$1.09M |
|
|
SAGE
3740
PUT
DELISTED
Sage Therapeutics
SAGE
| $6.43M | ﹤0.01% |
145,100
-199,500
| -58% | -$9.15M |
|
|
SRCL
3741
DELISTED
Stericycle Inc
SRCL
| $6.43M | ﹤0.01% |
94,546
+36,263
| +62% | +$2.5M |
|
|
CSR
3742
Centerspace
CSR
$941M
| $6.42M | ﹤0.01% |
67,947
+42,644
| +169% | +$4.01M |
|
3743
Alight
ALIT
$399M
| $6.42M | ﹤0.01% |
+27,962
| New | +$5.89M |
|
3744
CALL
Protolabs
PRLB
$2.14B
| $6.41M | ﹤0.01% |
96,200
-14,600
| -13% | -$1.14M |
|
3745
Invesco S&P International Developed Low Volatility ETF
IDLV
$345M
| $6.41M | ﹤0.01% |
209,120
+146,753
| +235% | +$4.65M |
|
|
AMRN
3746
Amarin Corp
AMRN
$304M
| $6.4M | ﹤0.01% |
62,725
+10,099
| +19% | +$992K |
|
3747
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
| $6.4M | ﹤0.01% |
84,398
+69,021
| +449% | +$5.26M |
|
|
AZUL
3748
DELISTED
Azul
AZUL
| $6.39M | ﹤0.01% |
318,777
+196,254
| +160% | +$4.3M |
|
|
AXNX
3749
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.38M | ﹤0.01% |
98,095
-284,377
| -74% | -$19.4M |
|
3750
Sysco
SYY
$40.6B
| $6.38M | ﹤0.01% |
81,326
-216,501
| -73% | -$16.5M |
|
Similar funds
Citadel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
- Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.